We are live on
!
Find out more
OCMI
Oaktop Capital Management II Portfolio holdings
AUM
$1.34B
1-Year Est. Return
114.5%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$465M
AUM Growth
-$13.8M
(-2.9%)
Cap. Flow
-$22.4M
Cap. Flow
% of AUM
-4.82%
Top 10 Holdings %
Top 10 Hldgs %
94.35%
Holding
18
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MXIM
Maxim Integrated Products
MXIM
|
+$570K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.44% |
| 2 | Healthcare | 38.79% |
| 3 | Industrials | 3.98% |
| 4 | Consumer Discretionary | 0.07% |
Similar funds
FFW
VV
NEWAS
BFMH
HAM
4WM
PO
WA
Oaktop Capital Management II's Q2 2019 Portfolio in Review
As of Q2 2019, Oaktop Capital Management II held 18 positions worth $465M, down 2.9% from $479M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Oaktop Capital Management II withdrew a net $22.4M in Q2 2019, reducing 1 holding. Its largest reduction was Celgene Corp, cutting an estimated $23M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Oaktop Capital Management II added an estimated $570K to Maxim Integrated Products.
- Oaktop Capital Management II added most to Maxim Integrated Products in Q2 2019, an estimated $570K increase.
- Oaktop Capital Management II's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $23M.
- Oaktop Capital Management II's ten largest holdings make up 94% of its $465M portfolio in Q2 2019.
- Oaktop Capital Management II opened 0 new positions and closed 0 in Q2 2019.
- Oaktop Capital Management II's portfolio value fell 2.9% quarter-over-quarter to $465M.
Based on Oaktop Capital Management II's 13F filing for Q2 2019, filed 7 Aug 2019.